{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T04:35:04Z","timestamp":1794544504344,"version":"4.9.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100006456","name":"Bundesministerium f\u00fcr Wirtschaftliche Zusammenarbeit und Entwicklung (DE)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006456","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12936-015-0909-7","type":"journal-article","created":{"date-parts":[[2015,9,26]],"date-time":"2015-09-26T04:16:08Z","timestamp":1443240968000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["Lack of effect of intermittent preventive treatment for malaria in pregnancy and intense drug resistance in western Uganda"],"prefix":"10.1186","volume":"14","author":[{"given":"Vera","family":"Braun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Rempis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Schnack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Decker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Rubaihayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazarius Mbona","family":"Tumwesigye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Theuring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gundel","family":"Harms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla","family":"Busingye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank P.","family":"Mockenhaupt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,26]]},"reference":[{"key":"909_CR1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1473-3099(07)70021-X","volume":"7","author":"M Desai","year":"2007","unstructured":"Desai M, ter Kuile FO, Nosten F, Asamoa K, Brabin B, Newman RD. Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis. 2007;7:93\u2013104.","journal-title":"Lancet Infect Dis"},{"key":"909_CR2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1473-3099(07)70022-1","volume":"7","author":"SJ Rogerson","year":"2007","unstructured":"Rogerson SJ, Hviid L, Duffy PE, Leke RF, Taylor DW. Malaria in pregnancy: pathogenesis and immunity. Lancet Infect Dis. 2007;7:105\u201317.","journal-title":"Lancet Infect Dis"},{"key":"909_CR3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/1475-2875-5-119","volume":"5","author":"FP Mockenhaupt","year":"2006","unstructured":"Mockenhaupt FP, Bedu-Addo G, von Gaertner C, Boy\u00e9 R, Fricke K, Hannibal I, et al. Detection and clinical manifestation of placental malaria in southern Ghana. Malar J. 2006;5:119.","journal-title":"Malar J"},{"key":"909_CR4","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1128\/JCM.40.1.306-308.2002","volume":"40","author":"FP Mockenhaupt","year":"2002","unstructured":"Mockenhaupt FP, Ulmen U, von Gaertner C, Bedu-Addo G, Bienzle U. Diagnosis of placental malaria. J Clin Microbiol. 2002;40:306\u20138.","journal-title":"J Clin Microbiol"},{"key":"909_CR5","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S1473-3099(13)70199-3","volume":"13","author":"AM Eijk van","year":"2013","unstructured":"van Eijk AM, Hill J, Larsen DA, Webster J, Steketee RW, Eisele TP, et al. Coverage of intermittent preventive treatment and insecticide-treated nets for the control of malaria during pregnancy in sub-Saharan Africa: a synthesis and meta-analysis of national survey data, 2009\u201311. Lancet Infect Dis. 2013;13:1029\u201342.","journal-title":"Lancet Infect Dis"},{"key":"909_CR6","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.pt.2013.08.002","volume":"29","author":"I Naidoo","year":"2013","unstructured":"Naidoo I, Roper C. Mapping \u2018partially resistant\u2019, \u2018fully resistant\u2019, and \u2018super resistant\u2019 malaria. Trends Parasitol. 2013;29:505\u201315.","journal-title":"Trends Parasitol"},{"key":"909_CR7","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1086\/592455","volume":"198","author":"FP Mockenhaupt","year":"2008","unstructured":"Mockenhaupt FP, Bedu-Addo G, Eggelte TA, Hommerich L, Holmberg V, von Oertzen C, et al. Rapid increase in the prevalence of sulfadoxine\u2013pyrimethamine resistance among Plasmodium falciparum isolated from pregnant women in Ghana. J Infect Dis. 2008;198:1545\u20139.","journal-title":"J Infect Dis"},{"key":"909_CR8","unstructured":"WHO. WHO policy brief for the implementation of intermittent preventive treatment of malaria in pregnancy using sulfadoxine\u2013pyrimethamine (IPTp-SP). Geneva: World Health Organization; 2013. http:\/\/www.who.int\/malaria\/publications\/atoz\/policy_brief_iptp_sp_policy_recommendation\/en\/ . Accessed 15 July 2015."},{"key":"909_CR9","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1001\/jama.2012.216231","volume":"309","author":"K Kayentao","year":"2013","unstructured":"Kayentao K, Garner P, van Eijk AM, Naidoo I, Roper C, Mulokozi A, et al. Intermittent preventive therapy for malaria during pregnancy using 2 vs 3 or more doses of sulfadoxine\u2013pyrimethamine and risk of low birth weight in Africa: systematic review and meta-analysis. JAMA. 2013;309:594\u2013604.","journal-title":"JAMA"},{"key":"909_CR10","doi-asserted-by":"crossref","first-page":"e1934","DOI":"10.1371\/journal.pone.0001934","volume":"3","author":"C Menendez","year":"2008","unstructured":"Menendez C, Bardaji A, Sigauque B, Romagosa C, Sanz S, Serra-Casas E, et al. A randomized placebo-controlled trial of intermittent preventive treatment in pregnant women in the context of insecticide treated nets delivered through the antenatal clinic. PLoS One. 2008;3:e1934.","journal-title":"PLoS One"},{"key":"909_CR11","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/cid\/cir376","volume":"53","author":"WE Harrington","year":"2011","unstructured":"Harrington WE, Mutabingwa TK, Kabyemela E, Fried M, Duffy PE. Intermittent treatment to prevent pregnancy malaria does not confer benefit in an area of widespread drug resistance. Clin Infect Dis. 2011;53:224\u201330.","journal-title":"Clin Infect Dis"},{"key":"909_CR12","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/tmi.12349","volume":"19","author":"D Mosha","year":"2014","unstructured":"Mosha D, Chilongola J, Ndeserua R, Mwingira F, Genton B. Effectiveness of intermittent preventive treatment with sulfadoxine\u2013pyrimethamine during pregnancy on placental malaria, maternal anaemia and birthweight in areas with high and low malaria transmission intensity in Tanzania. Trop Med Int Health. 2014;19:1048\u201356.","journal-title":"Trop Med Int Health"},{"key":"909_CR13","doi-asserted-by":"crossref","first-page":"e73073","DOI":"10.1371\/journal.pone.0073073","volume":"8","author":"E Arinaitwe","year":"2013","unstructured":"Arinaitwe E, Ades V, Walakira A, Ninsiima B, Mugagga O, Patil TS, et al. Intermittent preventive therapy with sulfadoxine\u2013pyrimethamine for malaria in pregnancy: a cross-sectional study from Tororo. Uganda. PLoS One. 2013;8:e73073.","journal-title":"Uganda. PLoS One"},{"key":"909_CR14","doi-asserted-by":"crossref","first-page":"9027","DOI":"10.1073\/pnas.0901415106","volume":"106","author":"WE Harrington","year":"2009","unstructured":"Harrington WE, Mutabingwa TK, Muehlenbachs A, Sorensen B, Bolla MC, Fried M, et al. Competitive facilitation of drug-resistant Plasmodium falciparum malaria parasites in pregnant women who receive preventive treatment. Proc Natl Acad Sci USA. 2009;106:9027\u201332.","journal-title":"Proc Natl Acad Sci USA"},{"key":"909_CR15","doi-asserted-by":"crossref","first-page":"e56183","DOI":"10.1371\/journal.pone.0056183","volume":"8","author":"WE Harrington","year":"2013","unstructured":"Harrington WE, Morrison R, Fried M, Duffy PE. Intermittent preventive treatment in pregnant women is associated with increased risk of severe malaria in their offspring. PLoS One. 2013;8:e56183.","journal-title":"PLoS One"},{"key":"909_CR16","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.3201\/eid1909.130133","volume":"19","author":"DT Minja","year":"2013","unstructured":"Minja DT, Schmiegelow C, Mmbando B, Bostr\u00f6m S, Oesterholt M, Magistrado P, et al. Plasmodium falciparum mutant haplotype infection during pregnancy associated with reduced birthweight, Tanzania. Emerg Infect Dis. 2013;19:1446\u201354.","journal-title":"Emerg Infect Dis"},{"key":"909_CR17","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1086\/338566","volume":"185","author":"JG Kublin","year":"2002","unstructured":"Kublin JG, Dzinjalamala FK, Kamwendo DD, Malkin EM, Cortese JF, Martino LM, et al. Molecular markers for failure of sulfadoxine\u2013pyrimethamine and chlorproguanil\u2013dapsone treatment of Plasmodium falciparum malaria. J Infect Dis. 2002;185:380\u20138.","journal-title":"J Infect Dis"},{"key":"909_CR18","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/1475-2875-9-247","volume":"9","author":"S Sridaran","year":"2010","unstructured":"Sridaran S, McClintock SK, Syphard LM, Herman KM, Barnwell JW, Udhayakumar V. Anti-folate drug resistance in Africa: meta-analysis of reported dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant genotype frequencies in African Plasmodium falciparum parasite populations. Malar J. 2010;9:247.","journal-title":"Malar J"},{"key":"909_CR19","doi-asserted-by":"crossref","first-page":"e4569","DOI":"10.1371\/journal.pone.0004569","volume":"4","author":"S Gesase","year":"2009","unstructured":"Gesase S, Gosling RD, Hashim R, Ord R, Naidoo I, Madebe R, et al. High resistance of Plasmodium falciparum to sulphadoxine\/pyrimethamine in northern Tanzania and the emergence of dhps resistance mutation at Codon 581. PLoS One. 2009;4:e4569.","journal-title":"PLoS One"},{"key":"909_CR20","unstructured":"WHO. WHO Evidence Review Group on Intermittent Preventive Treatment (IPT) of malaria in pregnancy. Geneva: World Health Organization; 2013. http:\/\/www.who.int\/malaria\/mpac\/mpac_sep13_erg_ipt_malaria_pregnancy_report.pdf . Accessed 16 July 2015."},{"key":"909_CR21","doi-asserted-by":"crossref","unstructured":"Chico RM, Cano J, Ariti C, Collier TJ, Chandramohan D, Roper C, Greenwood B. Influence of malaria transmission intensity and the 581G mutation on the efficacy of intermittent preventive treatment in pregnancy: systematic review and meta-analysis. Trop Med Int Health. 2015. doi: 10.1111\/tmi.12595 . [Epub ahead of print].","DOI":"10.1111\/tmi.12595"},{"key":"909_CR22","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1093\/infdis\/jiu836","volume":"211","author":"J Gutman","year":"2015","unstructured":"Gutman J, Kalilani L, Taylor S, Zhou Z, Wiegand RE, Thwai KL, et al. The A581G mutation in the gene encoding Plasmodium falciparum dihydropteroaten synthetase reduces the effectiveness of sulfadoxine\u2013pyrimethamine preventive therapy in Malawian pregnant women. J Infect Dis. 2015;211:1997\u20132005.","journal-title":"J Infect Dis"},{"key":"909_CR23","unstructured":"Ministry of Health Kampala, Uganda: Uganda Clinical Guidelines. Box 7272, 405 Kampala, Uganda 2010. http:\/\/apps.who.int\/medicinedocs\/documents\/s21741en\/s21741en.pdf . Accessed 23 Sept 2015."},{"key":"909_CR24","doi-asserted-by":"crossref","first-page":"5475","DOI":"10.1128\/AAC.00507-15","volume":"59","author":"AK Mbonye","year":"2015","unstructured":"Mbonye AK, Birungi J, Yanow SK, Shokoples S, Malamba S, Alifrangis M, et al. The prevalence of P. falciparum resistance markers to sulphadoxine\u2013pyrimethamine among pregnant women receiving intermittent preventive treatment of malaria in Uganda. Antimicrob Agents Chemother. 2015;59:5475\u201382.","journal-title":"Antimicrob Agents Chemother"},{"key":"909_CR25","doi-asserted-by":"crossref","first-page":"e13438","DOI":"10.1371\/journal.pone.0013438","volume":"5","author":"J Nankabirwa","year":"2010","unstructured":"Nankabirwa J, Cundill B, Clarke S, Kabatereine N, Rosenthal PJ, Dorsey G, et al. Efficacy, safety, and tolerability of three regimens for prevention of malaria: a randomized, placebo-controlled trial in Ugandan schoolchildren. PLoS One. 2010;5:e13438.","journal-title":"PLoS One"},{"key":"909_CR26","unstructured":"Cox J, Craig M, Le Sueur D, Sharp B. Mapping malaria risk in the highlands of Africa. MARA\/HIMAL. Technical report. 1999. https:\/\/idl-bnc.idrc.ca\/dspace\/bitstream\/10625\/31899\/1\/117291.pdf . Accessed 16 July 2015."},{"key":"909_CR27","unstructured":"Uganda Bureau of Statistics (UBOS) and ICF International. Uganda Malaria Indicator Survey 2014\u201315: key indicators. 2015. Kampala, Uganda, and Rockville, Maryland, USA: UBOS and ICF International. http:\/\/dhsprogram.com\/pubs\/pdf\/PR64\/PR64.pdf . Accessed 16 July 2015."},{"key":"909_CR28","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1111\/j.1365-3156.2008.02143.x","volume":"13","author":"KM Sullivan","year":"2008","unstructured":"Sullivan KM, Mei Z, Grummer-Strawn L, Parvanta I. Haemoglobin adjustments to define anaemia. Trop Med Int Health. 2008;13:1267\u201371.","journal-title":"Trop Med Int Health"},{"key":"909_CR29","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1651-2227.1977.tb07954.x","volume":"66","author":"O Finnstrom","year":"1977","unstructured":"Finnstrom O. Studies on maturity in newborn infants. IX. Further observations on the use of external characteristics in estimating gestational age. Acta Paediatr Scand. 1977;66:601\u20134.","journal-title":"Acta Paediatr Scand"},{"issue":"Suppl 1","key":"909_CR30","doi-asserted-by":"crossref","first-page":"S199","DOI":"10.1016\/S0035-9203(02)90077-5","volume":"96","author":"JM Rubio","year":"2002","unstructured":"Rubio JM, Post RJ, van Leeuwen WM, Henry MC, Lindergard G, Hommel M. Alternative polymerase chain reaction method to identify Plasmodium species in human blood samples: the semi-nested multiplex malaria PCR (SnM-PCR). Trans R Soc Trop Med Hyg. 2002;96(Suppl 1):S199\u2013204.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"909_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/expr.1998.4274","volume":"89","author":"MT Duraisingh","year":"1998","unstructured":"Duraisingh MT, Curtis J, Warhurst DC. Plasmodium falciparum: detection of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes by PCR and restriction digestion. Exp Parasitol. 1998;89:1\u20138.","journal-title":"Exp Parasitol"},{"key":"909_CR32","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1001\/jama.297.23.2603","volume":"297","author":"FO Kuile ter","year":"2007","unstructured":"ter Kuile FO, van Eijk AM, Filler SJ. Effect of sulfadoxine\u2013pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review. JAMA. 2007;297:2603\u201316.","journal-title":"JAMA"},{"key":"909_CR33","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/cid\/civ122","volume":"60","author":"G Cottrell","year":"2015","unstructured":"Cottrell G, Moussiliou A, Luty AJ, Cot M, Fievet N, Massougbodji A, et al. Submicroscopic Plasmodium falciparum infections are associated with maternal anemia, premature births, and low birth weight. Clin Infect Dis. 2015;60:1481\u20138.","journal-title":"Clin Infect Dis"},{"key":"909_CR34","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/infdis\/jiq072","volume":"203","author":"A Kapito-Tembo","year":"2011","unstructured":"Kapito-Tembo A, Meshnick SR, van Hensbroek MB, Phiri K, Fitzgerald M, Mwapasa V. Marked reduction in prevalence of malaria parasitemia and anemia in HIV-infected pregnant women taking cotrimoxazole with or without sulfadoxine\u2013pyrimethamine intermittent preventive therapy during pregnancy in Malawi. J Infect Dis. 2011;203:464\u201372.","journal-title":"J Infect Dis"},{"key":"909_CR35","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/cid\/cit806","volume":"58","author":"E Klement","year":"2014","unstructured":"Klement E, Pitch\u00e9 P, Kendjo E, Singo A, D\u2019Almeida S, Akouete F, et al. Effectiveness of co-trimoxazole to prevent Plasmodium falciparum malaria in HIV-positive pregnant women in sub-Saharan Africa: an open-label, randomized controlled trial. Clin Infect Dis. 2014;58:651\u20139.","journal-title":"Clin Infect Dis"},{"key":"909_CR36","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/1475-2875-8-254","volume":"8","author":"PM Newman","year":"2009","unstructured":"Newman PM, Wanzira H, Tumwine G, Arinaitwe E, Waldman S, Achan J, et al. Placental malaria among HIV-infected and uninfected women receiving anti-folates in a high transmission area of Uganda. Malar J. 2009;8:254.","journal-title":"Malar J"},{"key":"909_CR37","doi-asserted-by":"crossref","first-page":"e96017","DOI":"10.1371\/journal.pone.0096017","volume":"9","author":"C Manyando","year":"2014","unstructured":"Manyando C, Njunju EM, Mwakazanga D, Chongwe G, Mkandawire R, Champo D, et al. Safety of daily co-trimoxazole in pregnancy in an area of changing malaria epidemiology: a phase 3b randomized controlled clinical trial. PLoS One. 2014;9:e96017.","journal-title":"PLoS One"},{"key":"909_CR38","volume-title":"Guidelines for the treatment of malaria","author":"WHO","year":"2010","unstructured":"WHO. Guidelines for the treatment of malaria. 2nd ed. Geneva: World Health Organization; 2010.","edition":"2"},{"key":"909_CR39","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1128\/AAC.00856-06","volume":"51","author":"FP Mockenhaupt","year":"2007","unstructured":"Mockenhaupt FP, Bedu-Addo G, Junge C, Hommerich L, Eggelte TA, Bienzle U. Markers of sulfadoxine\u2013pyrimethamine-resistant Plasmodium falciparum in placenta and circulation of pregnant women. Antimicrob Agents Chemother. 2007;51:332\u20134.","journal-title":"Antimicrob Agents Chemother"},{"key":"909_CR40","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.3201\/eid2008.131897","volume":"20","author":"M Alifrangis","year":"2014","unstructured":"Alifrangis M, Nag S, Schousboe ML, Ishengoma D, Lusingu J, Pota H, et al. Independent origin of Plasmodium falciparum antifolate super-resistance, Uganda, Tanzania, and Ethiopia. Emerg Infect Dis. 2014;20:1280\u20136.","journal-title":"Emerg Infect Dis"},{"key":"909_CR41","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1475-2875-11-134","volume":"11","author":"NC Iriemenam","year":"2012","unstructured":"Iriemenam NC, Shah M, Gatei W, van Eijk AM, Ayisi J, Kariuki S, et al. Temporal trends of sulphadoxine\u2013pyrimethamine (SP) drug-resistance molecular markers in Plasmodium falciparum parasites from pregnant women in western Kenya. Malar J. 2012;11:134.","journal-title":"Malar J"},{"key":"909_CR42","doi-asserted-by":"crossref","first-page":"523","DOI":"10.4269\/ajtmh.2009.80.523","volume":"80","author":"M Alifrangis","year":"2009","unstructured":"Alifrangis M, Lusingu JP, Mmbando B, Dalgaard MB, Vestergaard LS, Ishengoma D, et al. Five-year surveillance of molecular markers of Plasmodium falciparum antimalarial drug resistance in Korogwe District, Tanzania: accumulation of the 581G mutation in the P. falciparum dihydropteroate synthase gene. Am J Trop Med Hyg. 2009;80:523\u20137.","journal-title":"Am J Trop Med Hyg"},{"key":"909_CR43","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1086\/587845","volume":"197","author":"C Lynch","year":"2008","unstructured":"Lynch C, Pearce R, Pota H, Cox J, Abeku TA, Rwakimari J, et al. Emergence of a dhfr mutation conferring high-level drug resistance in Plasmodium falciparum populations from southwest Uganda. J Infect Dis. 2008;197:1598\u2013604.","journal-title":"J Infect Dis"},{"key":"909_CR44","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.actatropica.2011.09.009","volume":"121","author":"I Zeile","year":"2012","unstructured":"Zeile I, Gahutu JB, Shyirambere C, Steininger C, Musemakweri A, Sebahungu F, et al. Molecular markers of Plasmodium falciparum drug resistance in southern highland Rwanda. Acta Trop. 2012;121:50\u20134.","journal-title":"Acta Trop"},{"key":"909_CR45","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1186\/1475-2875-9-338","volume":"9","author":"MD Spalding","year":"2010","unstructured":"Spalding MD, Eyase FL, Akala HM, Bedno SA, Prigge ST, Coldren RL, et al. Increased prevalence of the pfdhfr\/phdhps quintuple mutant and rapid emergence of pfdhps resistance mutations at codons 581 and 613 in Kisumu, Kenya. Malar J. 2010;9:338.","journal-title":"Malar J"},{"key":"909_CR46","doi-asserted-by":"crossref","first-page":"e1001733","DOI":"10.1371\/journal.pmed.1001733","volume":"11","author":"R Gonz\u00e1lez","year":"2014","unstructured":"Gonz\u00e1lez R, Mombo-Ngoma G, Ou\u00e9draogo S, Kakolwa MA, Abdulla S, Accrombessi M, et al. Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-negative women: a multicentre randomized controlled trial. PLoS Med. 2014;11:e1001733.","journal-title":"PLoS Med"},{"key":"909_CR47","doi-asserted-by":"crossref","first-page":"e14425","DOI":"10.1371\/journal.pone.0014425","volume":"5","author":"H Tagbor","year":"2010","unstructured":"Tagbor H, Bruce J, Agbo M, Greenwood B, Chandramohan D. Intermittent screening and treatment versus intermittent preventive treatment of malaria in pregnancy: a randomised controlled non-inferiority trial. PLoS One. 2010;5:e14425.","journal-title":"PLoS One"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-015-0909-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T20:50:55Z","timestamp":1567198255000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.malariajournal.com\/content\/14\/1\/372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,26]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["909"],"URL":"https:\/\/doi.org\/10.1186\/s12936-015-0909-7","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,26]]},"article-number":"372"}}